Health News - Diabetic Life. Learn about Juvenile Diabetes, Heart Disease, Glucose testing and much more.
A Member of the Healthscout Network
 Printer Friendly  Send to a Friend

Chronic Kidney Disease Growing Globally

Researchers urge countries to make condition a public health priority

THURSDAY, June 26 (HealthDay News) -- The already high worldwide rate of chronic kidney disease (CKD) is increasing, and the fact it raises a person's risk of death should make the disease a public health priority, say Taiwanese researchers.

They analyzed data on 462,293 people in Taiwan over age 20 who took part in a standard medical screening program in 1994. The participants were observed for 13 years, with a median follow-up of 7.5 years.

Advertisement
Related Stories
 border=
Bariatric Surgery Before Pregnancy Benefits Moms, Babies
Cancer Drugs May Treat Type 1 Diabetes
Greener Neighborhoods Mean Slimmer Children
Related Videos
 border=
Natural Treatment for Autoimmune Disease
Eliminating Disease - Part I
Eliminating Disease
Related Slides
 border=
Diabetes
Thyroid Disease
Diabetic Retinopathy
Related Encyclopedia
 border=
Addison's Disease
Carcinoid Syndrome
Congenital Adrenal Hyperplasia


The 56,777 (12 percent) people with CKD were 83 percent more likely to die from all causes and twice as likely to die from cardiovascular causes than those without CKD, the study found. Almost 40 percent of deaths in the CKD group occurred before age 65.

Of the deaths in the entire study group, 10.3 percent were attributable to CKD, but this figure increased to 17.5 percent among people with low socioeconomic status. The rate of CKD was higher among people with low socioeconomic status (19.8 percent) than among those with high socioeconomic status. Of those with CKD, only 3.54 percent were aware of their condition. In the United States, that figure is 10 percent.

Interestingly, the researchers also found that people who regularly used Chinese herbal medicines had a 20 percent increased risk of developing CKD.

The number of people in the study affected by CKD was several times more than that for diabetes, and more than half the number affected by high blood pressure.

The study was published in this week's issue of The Lancet.

Under diagnosis and under treatment of CKD is a worldwide issue, the researchers said.

"The high prevalence and its associated all-cause mortality, especially in people with low socioeconomic status, make reduction of CKD a public health priority. Promotion of its recognition through the general public knowing their GFR [glomerular filtration rate] and testing their urine is crucial to reduce premature deaths from all causes and to attenuate this global epidemic," the study authors concluded.

More information

The National Kidney Foundation has more about chronic kidney disease.

-- Robert Preidt

SOURCE: The Lancet, news release, June 27, 2008

Copyright © 2008 ScoutNews, LLC. All rights reserved.
Last updated 6/26/2008



Disclaimer: The information provided on this website is for educational purposes only and does not serve as a replacement for care provided by your own personal health care team. This website does not render or provide medical advice, and no individual should make any medical decisions or change their health behavior based on information provided here. All pertinent content provided on this website should be discussed with your personal physician to evaluate whether it has any relevance to or impact on your specific condition. Reliance on any information provided by this website is solely at your own risk.


Nov 21, 2008
Home
Search
Powered By HealthLine
New! For timely and trustworth health information, expert advice and much more, visit Diabetes Connections
Patient Guide
News
Health Videos
Health Encyclopedia
Health News Archive
Affiliate Information
HealthScout Network
Contact Us
Newsletters
Privacy Policy
Terms of Use

We comply with the HONcode standard for trustworthy health
information:
verify here.
About The HealthScout Network Contact Us
Copyright © 2001. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service  

To find more information on specific conditions, please visit our partner sites: